Literature DB >> 31154012

Autophagy and mitophagy in cancer metabolic remodelling.

Fabio Ferro1, Stéphane Servais1, Pierre Besson1, Sébastien Roger2, Jean-François Dumas1, Lucie Brisson3.   

Abstract

Metabolic reprogramming in tumours is now recognized as a hallmark of cancer, participating both in tumour growth and cancer progression. Cancer cells develop global metabolic adaptations allowing them to survive in the low oxygen and nutrient tumour microenvironment. Among these metabolic adaptations, cancer cells use glycolysis but also mitochondrial oxidations to produce ATP and building blocks needed for their high proliferation rate. Another particular adaptation of cancer cell metabolism is the use of autophagy and specific forms of autophagy like mitophagy to recycle intracellular components in condition of metabolic stress or during anticancer treatments. The plasticity of cancer cell metabolism is a major limitation of anticancer treatments and could participate to therapy resistances. The aim of this review is to report recent advances in the understanding of the relationship between tumour metabolism and autophagy/mitophagy in order to propose new therapeutic strategies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; Cancer metabolism; Ion channel; Mitochondria; Mitophagy; ROS

Mesh:

Year:  2019        PMID: 31154012     DOI: 10.1016/j.semcdb.2019.05.029

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  41 in total

Review 1.  Mitochondrion: I am more than a fuel server.

Authors:  Santanu Dasgupta
Journal:  Ann Transl Med       Date:  2019-10

2.  Autophagy and Tumor Database: ATdb, a novel database connecting autophagy and tumor.

Authors:  Kelie Chen; Dexin Yang; Fan Zhao; Shengchao Wang; Yao Ye; Wenjie Sun; Haohua Lu; Zhi Ruan; Jinming Xu; Tianru Wang; Guang Lu; Liming Wang; Yu Shi; Honghe Zhang; Han Wu; Weiguo Lu; Han-Ming Shen; Dajing Xia; Yihua Wu
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

3.  The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells.

Authors:  Jie Li; Ekta Agarwal; Irene Bertolini; Jae Ho Seo; M Cecilia Caino; Jagadish C Ghosh; Andrew V Kossenkov; Qin Liu; Hsin-Yao Tang; Aaron R Goldman; Lucia R Languino; David W Speicher; Dario C Altieri
Journal:  Sci Signal       Date:  2020-07-28       Impact factor: 8.192

Review 4.  The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues.

Authors:  Anna Sebestyén; Titanilla Dankó; Dániel Sztankovics; Dorottya Moldvai; Regina Raffay; Catherine Cervi; Ildikó Krencz; Viktória Zsiros; András Jeney; Gábor Petővári
Journal:  Cancer Metastasis Rev       Date:  2022-01-14       Impact factor: 9.264

Review 5.  The Regulatory Roles of Mitochondrial Calcium and the Mitochondrial Calcium Uniporter in Tumor Cells.

Authors:  Linlin Zhang; Jingyi Qi; Xu Zhang; Xiya Zhao; Peng An; Yongting Luo; Junjie Luo
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 6.  Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements.

Authors:  Vaishali Aggarwal; Hardeep Singh Tuli; Ayşegül Varol; Falak Thakral; Mukerrem Betul Yerer; Katrin Sak; Mehmet Varol; Aklank Jain; Md Asaduzzaman Khan; Gautam Sethi
Journal:  Biomolecules       Date:  2019-11-13

Review 7.  mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer.

Authors:  Karen Griselda de la Cruz López; Mariel Esperanza Toledo Guzmán; Elizabeth Ortiz Sánchez; Alejandro García Carrancá
Journal:  Front Oncol       Date:  2019-12-13       Impact factor: 6.244

Review 8.  Metformin: Metabolic Rewiring Faces Tumor Heterogeneity.

Authors:  Mario Cioce; Claudio Pulito; Sabrina Strano; Giovanni Blandino; Vito Michele Fazio
Journal:  Cells       Date:  2020-11-09       Impact factor: 6.600

9.  Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells.

Authors:  Guangya Xu; Xueling Yan; Zhongjia Hu; Lulu Zheng; Ke Ding; Yamei Zhang; Yi Qing; Tao Liu; Lijia Cheng; Zheng Shi
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

10.  Tubeimoside I induces autophagy in HepG2 cells by activating the AMP-activated protein kinase signaling pathway.

Authors:  Chengxu Ruan; Lijuan You; Yingdong Qiu; Xiao Cui; Defeng Wu
Journal:  Oncol Lett       Date:  2020-05-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.